Zurueck zur Suche

Reporte zur Charge U015480

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NC 3 NY 2 IL 2 IA 1 OH 1 VA 1

VAERS 2410354

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
IA
Alter
11,0
Geschlecht
F
Eingang
12.08.2022
Impfdatum
05.08.2022
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

N/A Patient's mother reported no adverse events.on 8/8/22 via telephone call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2334806

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
25.06.2022
Impfdatum
19.05.2022
Beginn
19.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additonal AE's and no PQC's were; A nurse stated that an improperly stored dose of PROQUAD was administered to a patient. No additonal AE's and no PQC's were reported.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-MAY-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, use as directed to prevent measles, mumps, rubella and varicella infection, lot #U015480, expiration date: reported as 13-NOV-2023 but auto-populated as 13-NOV-2022 (site and route of administration were not provided) (product storage issue). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2283150

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
NC
Alter
17,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Patient was given ProQuad and Menactra together.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Zyrtec
Allergien
tree nuts
Vorherige Impfungen
-

VAERS 2283136

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
NC
Alter
17,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was mistakenly given ProQuad and Menactra together. At this time she is not experiencing an adverse reaction. Called to report and was advised to fill out this VAERS form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Zyrtec
Allergien
tree nuts
Vorherige Impfungen
-

VAERS 2283136

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015480

gering
Staat
NC
Alter
17,0
Geschlecht
F
Eingang
18.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was mistakenly given ProQuad and Menactra together. At this time she is not experiencing an adverse reaction. Called to report and was advised to fill out this VAERS form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Zyrtec
Allergien
tree nuts
Vorherige Impfungen
-

VAERS 2268422

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
NY
Alter
1,2
Geschlecht
U
Eingang
10.05.2022
Impfdatum
25.04.2022
Beginn
25.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event Product use issue Underdose Wrong product administered

Symptomtext

No additional AE reported; A nurse reported a patient inadvertently received PROQUAD instead of MMR II.Interchange of vaccine products; A nurse reported a patient inadvertently received PROQUAD instead of MMR II.; She also states only about half of the medication (0.25mL) was administered because the patient moved their leg during administration and the needle slipped out.; This spontaneous report was received from a nurse and refers to a 14-month-old patient, of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions, and concomitant medications were not provided. On 24-APR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin-rHA) (PROQUAD), 0.25 ml administered, lot number U015480, expiration date: reported as 13-NOV-2022, (strength, and route of administration were not provided), instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (wrong vaccine administered-drug use for unapproved schedule). Also, the patient only received the half of the vaccine dose (0.25 milligram (ml)) because the patient moved their leg during the administration and the needle slipped out (incomplete dose administered). On the same date, the patient was also vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX); and pneumococcal vaccine conj 13v (crm197) (PREVNAR 13),(strength, formulation, dose description, lot number, expiry date, and route of administration were not provided for none on both), which the nurse reported that the patient received the full dose of both vaccines. No additional adverse event was reported. .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2250198

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
NY
Alter
1,2
Geschlecht
M
Eingang
25.04.2022
Impfdatum
25.04.2022
Beginn
25.04.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Patient was given a full Varivax and half of a Proquad in error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2112782

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
IL
Alter
9,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
10.02.2022
Beginn
10.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered Product administered to patient of inappropriate age

Symptomtext

Child inadvertently given Adult formulation of Engerix B- Hepatitis B vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2112769

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
IL
Alter
11,0
Geschlecht
F
Eingang
15.02.2022
Impfdatum
10.02.2022
Beginn
10.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

Child was inadvertently given Adult formulation of Engerix B (Hepatitis B) vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1892615

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U015480

gering
Staat
VA
Alter
14,0
Geschlecht
U
Eingang
23.11.2021
Impfdatum
27.10.2021
Beginn
27.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional adverse events; administration of PROQUAD to a 14 year old; This spontaneous report was received from a nurse referring to a 14 year old patient. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided. The nurse reported that the patient had incomplete vaccination history and had a separate dose of "MMR and varicella" in May 2012. On 27-OCT-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # U015480, expiration date 13-NOV-2022 at a dose of 0.5 milliliter for prophylaxis (product administered to patient of inappropriate age). The patient was not experiencing any symptoms at this time. No additional adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-